Evidence map›Paper›PMID 35857842›Full record

ArticleScience advances2022

G6PD-mediated increase in de novo NADP

Yang Zhang, Yi Xu, Wenyun Lu, Jinyang Li, Sixiang Yu, Eric J Brown, Ben Z Stanger, Joshua D Rabinowitz, Xiaolu Yang

Open access · goldAbstract read
In one paragraph

Article in Science advances, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 47 papers.

0numbers the graph read from it
0cells of the map it votes in
47citing papers in PubMed
4.6field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

47 citing papers in PubMed, 50 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Male germ cell-specific deletion ofZoological research · 2026
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Yang ZhangDepartment of Cancer Biology, University of Pennsylvania, Philadelphia, PA 19104, USA.ORCID 0000-0003-2315-9009
Yi XuDepartment of Cancer Biology, University of Pennsylvania, Philadelphia, PA 19104, USA.ORCID 0000-0001-6052-3530
Wenyun LuLewis-Sigler Institute for Integrative Genomics, Princeton University, Princeton, NJ 08540, USA.
Jinyang LiAbramson Family Cancer Research Institute, University of Pennsylvania, Philadelphia, PA 19104, USA.
Sixiang YuDepartment of Cancer Biology, University of Pennsylvania, Philadelphia, PA 19104, USA.ORCID 0000-0003-0967-7838
Eric J BrownDepartment of Cancer Biology, University of Pennsylvania, Philadelphia, PA 19104, USA.ORCID 0000-0001-6562-6512
Ben Z StangerAbramson Family Cancer Research Institute, University of Pennsylvania, Philadelphia, PA 19104, USA.ORCID 0000-0003-0410-4037
Joshua D RabinowitzLewis-Sigler Institute for Integrative Genomics, Princeton University, Princeton, NJ 08540, USA.ORCID 0000-0002-1247-4727
Xiaolu YangDepartment of Cancer Biology, University of Pennsylvania, Philadelphia, PA 19104, USA.ORCID 0000-0001-6755-7725
Cancer Research Institute · USPrinceton University · USUniversity of Pennsylvania · US

Funding

Translational Research Support CoreP30ES013508 · NIEHS · UNIVERSITY OF PENNSYLVANIA · PI Trevor M Penning · 2006 to 2026
$35.3M
TRANSGENIC AND CHIMERIC MOUSE COREP30DK050306 · NIDDK · UNIVERSITY OF PENNSYLVANIA · PI REBECCA G WELLS · 1997 to 2026
$32.5M
Training In Tumor VirologyT32CA115299 · NCI · UNIVERSITY OF PENNSYLVANIA · PI ROBERTSON, ERLE S. · 2006 to 2021
$4.7M
A novel protein quality control system and its role in tumorigenesisR01CA243520 · NCI · UNIVERSITY OF PENNSYLVANIA · PI YANG, XIAOLU · 2020 to 2024
$2.2M
Role of Daxx in protein folding and tumorigenesisR01CA235760 · NCI · UNIVERSITY OF PENNSYLVANIA · PI YANG, XIAOLU · 2019 to 2023
$1.8M
p53 and tumor cell metabolismR01CA182675 · NCI · UNIVERSITY OF PENNSYLVANIA · PI YANG, XIAOLU · 2014 to 2018
$1.7M
Revealing cancer metabolism via mass spectrometry and isotope tracersR50CA211437 · NCI · PRINCETON UNIVERSITY · PI Wenyun Lu · 2016 to 2026
$1.3M
Role of p53 family proteins in glucose metabolismR01CA184867 · NCI · UNIVERSITY OF PENNSYLVANIA · PI YANG, XIAOLU · 2014 to 2017
$1.3M
NCI NIH HHS R01 CA182675NCI NIH HHS R01 CA184867NCI NIH HHS R01 CA235760NCI NIH HHS R01 CA243520NCI NIH HHS R50 CA211437NCI NIH HHS T32 CA115299NIDDK NIH HHS P30 DK050306NIEHS NIH HHS P30 ES013508
6 · The paper itself

Abstract

Metastasizing cancer cells are able to withstand high levels of oxidative stress through mechanisms that are poorly understood. Here, we show that under various oxidative stress conditions, pancreatic cancer cells markedly expand NADPH and NADP

Indexed as

Glucosephosphate DehydrogenasePancreatic NeoplasmsAntioxidantsHumansNADPOxidation-ReductionAntioxidantsGlucosephosphate DehydrogenaseNADP

Identifiers

PMID35857842
PMCPMC9299539
OpenAlexW4285987592

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.